LobbyingAmerican Society of Consultant Pharmacists lobbying by quarter
American Society of Consultant Pharmacists's latest lobbying report covers Q2 2026, at $15K. The four quarters Q4 2025–Q3 2026 total $45K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
American Society of Consultant Pharmacists
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $45K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $15K | 1 |
| Q1 2023 | $15K | 1 |
| Q2 2023 | $15K | 1 |
| Q3 2023 | $15K | 1 |
| Q4 2023 | $15K | 1 |
| Q1 2024 | $15K | 1 |
| Q2 2024 | $15K | 1 |
| Q3 2024 | $15K | 1 |
| Q4 2024 | $15K | 1 |
| Q1 2025 | $15K | 1 |
| Q2 2025 | $15K | 1 |
| Q3 2025 | $15K | 1 |
| Q4 2025 | $15K | 1 |
| Q1 2026 | $15K | 1 |
| Q2 2026 | $15K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$78.8K · 15 reports
- Medicare and Medicaid$78.8K · 15 reports
- Pharmacy$56.3K · 12 reports
- Medical research and clinical labs$11.3K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)15 reports
- Health & Human Services, Dept of (HHS)15 reports
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Food & Drug Administration (FDA)10 reports
- White House Office10 reports
- Centers For Disease Control & Prevention (CDC)7 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAmerican Society of Consultant Pharmacists | $225K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JAMES CALVIN LEWIS jr | Senior Director of Policy and Advocacy | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/19for Q2 | In-house | $15K |
| 04/20for Q1 | In-house | $15K |
| 01/20for Q4 2025 | In-house | $15K |
| 25/10/20for Q3 2025 | In-house | $15K |
| 25/07/15for Q2 2025 | In-house | $15K |
| 25/04/21for Q1 2025 | In-house | $15K |
| 25/01/31for Q4 2024 | In-house | $15K |
| 24/10/22for Q3 2024 | In-house | $15K |
| 24/07/22for Q2 2024 | In-house | $15K |
| 24/04/15for Q1 2024 | In-house | $15K |
| 24/01/23for Q4 2023 | In-house | $15K |
| 23/10/20for Q3 2023 | In-house | $15K |
| 23/07/14for Q2 2023 | In-house | $15K |
| 23/04/20for Q1 2023 | In-house | $15K |
| 23/01/20for Q4 2022 | In-house | $15K |